연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1871. A new fluorescence/PET probe for targeting intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated IgM.
Jung KO, Youn HW, Kim SH, Kim YH, Kang KW, Chung JK.
Biochem Biophys Res Commun. 2016 Aug 26;477(3):483-9. doi: 10.1016/j.bbrc.2016.06.068. Epub 2016 Jun 15.
Link
1870. Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse.
Ryu J, Koh Y, Park H, Kim DY, Kim DC, Byun JM, Lee HJ, Yoon SS.
Mol Cells. 2016 Dec;39(12):898-908. doi: 10.14348/molcells.2016.0210. Epub 2016 Dec 21.
Link
1869. MCM7 polymorphisms associated with the AML relapse and overall survival.
Lee JS, Cheong HS, Koh Y, Ahn KS, Shin HD, Yoon SS.
Ann Hematol. 2017 Jan;96(1):93-98. doi: 10.1007/s00277-016-2844-2. Epub 2016 Nov 12.
Link
1868. SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.
Kim JH, Lee C, Cheong HS, Koh Y, Ahn KS, Kim HL, Shin HD, Yoon SS.
Cancer Chemother Pharmacol. 2016 Sep;78(3):533-40. doi: 10.1007/s00280-016-3103-x. Epub 2016 Jul 15.
Link
1867. Implication of Tumor Location for Lymph Node Metastasis in Maxillary Sinus Carcinoma: Indications for Elective Neck Treatment
Jeon SH, Han DH, Won TB, Keam B, Kim JH, Wu HG
J Oral Maxillofac Surg. 2016 Oct 13. pii: S0278-2391(16)30946-6. doi: 10.1016/j.joms.2016.10.004
Link
1866. Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era
Lee SW, Kang KW, Wu HG
Head Neck. 2016 Apr;38 Suppl 1:E1746-55
Link
1865. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.
Cho KM, Park H, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ.
Oncotarget. 2016 Nov 30. doi: 10.18632/oncotarget.13731. [Epub ahead of print]
Link
1864. Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy.
Ha H, Nam AR, Bang JH, Park JE, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ, Oh DY.
Oncotarget. 2016 Nov 22;7(47):76604-76612. doi: 10.18632/oncotarget.12810.
Link
1863. Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment.
An E, Ock CY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Liao WL, Cecchi F, Blackler A, Thyparambil S, Kim WH, Burrows J, Hembrough T, Catenacci DV, Oh DY, Bang YJ.
Ann Oncol. 2016 Sep 29. pii: mdw442. doi: 10.1093/annonc/mdw442. [Epub ahead of print]
Link
1862. Therapeutic implication of HER2 in advanced biliary tract cancer.
Nam AR, Kim JW, Cha Y, Ha H, Park JE, Bang JH, Jin MH, Lee KH, Kim TY, Han SW, Im SA, Kim TY, Oh DY, Bang YJ.
Oncotarget. 2016 Sep 6;7(36):58007-58021. doi: 10.18632/oncotarget.11157.
Link